Affiliation:
1. Department of Pharmacology and Pharmaceutical Sciences, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA
Abstract
Lipid-based nanoparticles (LBNPs) are an important tool for the delivery of a diverse set of drug cargoes, including small molecules, oligonucleotides, and proteins and peptides. Despite their development over the past several decades, this technology is still hindered by issues with the manufacturing processes leading to high polydispersity, batch-to-batch and operator-dependent variability, and limits to the production volumes. To overcome these issues, the use of microfluidic techniques in the production of LBNPs has sharply increased over the past two years. Microfluidics overcomes many of the pitfalls seen with conventional production methods, leading to reproducible LBNPs at lower costs and higher yields. In this review, the use of microfluidics in the preparation of various types of LBNPs, including liposomes, lipid nanoparticles, and solid lipid nanoparticles for the delivery of small molecules, oligonucleotides, and peptide/protein drugs is summarized. Various microfluidic parameters, as well as their effects on the physicochemical properties of LBNPs, are also discussed.
Reference100 articles.
1. Emerging Research and Clinical Development Trends of Liposome and Lipid Nanoparticle Drug Delivery Systems;Kraft;J. Pharm. Sci.,2014
2. Bangham, A.D., Standish, M.M., and Watkins, J.C. (1965). Diffusion of Univalent Ions across the Lamellae of Swollen Phospholipids. J. Mol. Biol., 13.
3. Liposome-like Nanostructures for Drug Delivery;Gao;J. Mater. Chem. B,2013
4. The Role of Lipid Components in Lipid Nanoparticles for Vaccines and Gene Therapy;Kulkarni;Adv. Drug Deliv. Rev.,2022
5. Application of Lipid-Based Nanoparticles in Cancer Immunotherapy;Zhang;Front. Immunol.,2022
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献